Assessing vaccine durability in randomized trials following placebo crossover

DOI10.1002/SIM.9001zbMATH Open1546.62229MaRDI QIDQ6628297

Author name not available (Why is that?), Dean A. Follmann

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

vaccine efficacyproportional hazards regressionCOVID-19vaccine trial design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Title not available (Why is that?)
• Does Cox analysis of a randomized survival study yield a causal treatment effect?
• Flexible smoothing with \(B\)-splines and penalties. With comments and a rejoinder by the authors
• Design and Analysis of Crossover Trials for Absorbing Binary Endpoints
• Estimation of Waning Vaccine Efficacy
• Augmented Designs to Assess Immune Response in Vaccine Trials

Related Items (1)

Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated

This page was built for publication: Assessing vaccine durability in randomized trials following placebo crossover

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628297)